EUVIMEDEUVIMED entdecken
Crossref

Open‐Source Throttling of CD8 + T Cells in Brain with Low‐Intensity Focused Ultrasound‐Guided Sequential Delivery of CXCL10, IL‐2, and aPD‐L1 for Glioblastoma Immunotherapy

Lei Dong, Yini Zhu, Haoge Zhang, Lin Gao, Zhiqi Zhang, Xiaoxuan Xu, Leqian Ying, Lu Zhang, Yue Li, Zhengcheng Yun, Danqi Zhu, Chang Han und 6 weitere

Advanced Materials · 2024

DOI: 10.1002/adma.202407235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Lei Dong und 17 weiteren Autor:innen. Beteiligte Einrichtung: Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology; Department of Oncology, Zhongda Hospital, Medical…. Hauptthemen laut MEDLINE: Glioblastoma, CD8-Positive T-Lymphocytes, Immunotherapy, B7-H1 Antigen. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, SEU Innovation Capability Enhancement Plan for Doctoral Students, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Improving clinical immunotherapy for glioblastoma (GBM) relies on addressing the immunosuppressive tumor microenvironment (TME). Enhancing CD8 + T cell infiltration and preventing its exhaustion holds promise for effective GBM immunotherapy. Here, a low‐intensity focused ultrasound (LIFU)‐guided sequential delivery strategy is developed to enhance CD8 + T cells infiltration and activity in the GBM region. The sequential delivery of CXC chemokine ligand 10 (CXCL10) to recruit CD8 + T cells and interleukin‐2 (IL‐2) to reduce their exhaustion is termed an “open‐source throttling” strategy. Consequently, up to 3.39‐fold of CD8 + T cells are observed with LIFU‐guided sequential delivery of CXCL10, IL‐2, and anti‐programmed cell death 1 ligand 1 (aPD‐L1), compared to the free aPD‐L1 group. The immune checkpoint inhibitors (ICIs) therapeutic efficacy is substantially enhanced by the reversed immunosuppressive TME due to the expansion of CD8 + T cells, resulting in the elimination of tumor, prolonged survival time, and long‐term immune memory establishment in orthotopic GBM mice. Overall, LIFU‐guided sequential cytokine and ICIs delivery offers an “open‐source throttling” strategy of CD8 + T cells, which may present a promising strategy for brain‐tumor immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaCD8-Positive T-LymphocytesImmunotherapyB7-H1 AntigenBrain NeoplasmsChemokine CXCL10Interleukin-2AnimalsMiceCell Line, TumorHumansTumor MicroenvironmentBrainUltrasonic Waves

Stichwörter der Autor:innen

CXCL10IL‐2T‐cell exhaustionglioblastomaimmune checkpoint inhibitorsimmunosuppressive microenvironmentlow‐frequency focused ultrasound

Substanzen

B7-H1 AntigenChemokine CXCL10Interleukin-2

Autor:innen und Institutionen

  • Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology; Department of Oncology, Zhongda Hospital, Medical School, Southeast University, 87 Dingjiaqiao, Nanjing, 210009, China.
  • Department of Microbiology and Immunology, Medical School of Southeast University, Nanjing, Jiangsu, 210009, China.
  • Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology, Basic Medicine Research and Innovation Center of Ministry of Education, State Key Laboratory of Digital Medical Enginee…
  • State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, 999078, China.
  • Department of Biochemistry and Molecular Biology, Medical School of Southeast University, Nanjing, China.
  • Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, S…

ORCID-Profile: Jinbing Xie

Förderung

  • National Natural Science Foundation of China
  • SEU Innovation Capability Enhancement Plan for Doctoral Students
  • National Key Research and Development Program of China

Zitieren

APA

Dong, L., Zhu, Y., Zhang, H., Gao, L., Zhang, Z., Xu, X., Ying, L., Zhang, L., Li, Y., Yun, Z., Zhu, D., Han, C., Xu, T., Yang, H., Ju, S., Chen, X., Zhang, H., & Xie, J. (2024). Open‐Source Throttling of CD8 + T Cells in Brain with Low‐Intensity Focused Ultrasound‐Guided Sequential Delivery of CXCL10, IL‐2, and aPD‐L1 for Glioblastoma Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.202407235

Vancouver

Dong L, Zhu Y, Zhang H, Gao L, Zhang Z, Xu X, et al. Open‐Source Throttling of CD8 + T Cells in Brain with Low‐Intensity Focused Ultrasound‐Guided Sequential Delivery of CXCL10, IL‐2, and aPD‐L1 for Glioblastoma Immunotherapy. Advanced Materials. 2024. doi:10.1002/adma.202407235

BibTeX
@article{Dong2024,
  author = {Dong, Lei and Zhu, Yini and Zhang, Haoge and Gao, Lin and Zhang, Zhiqi and Xu, Xiaoxuan and Ying, Leqian and Zhang, Lu and Li, Yue and Yun, Zhengcheng and Zhu, Danqi and Han, Chang and Xu, Tingting and Yang, Hui and Ju, Shenghong and Chen, Xiaoyuan and Zhang, Haijun and Xie, Jinbing},
  title = {Open‐Source Throttling of CD8 + T Cells in Brain with Low‐Intensity Focused Ultrasound‐Guided Sequential Delivery of CXCL10, IL‐2, and aPD‐L1 for Glioblastoma Immunotherapy},
  journal = {Advanced Materials},
  year = {2024},
  doi = {10.1002/adma.202407235}
}
Kostenlos starten →